Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
E25Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
E25Bio

E25Bio

Series A

E25Bio Inc., a Venture Capital-backed firm, develops rapid diagnostic tests for infectious diseases.

HQ
Cambridge, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

E25Bio Inc., founded with the support of Venture Capital and grants from the NIH and Gates Foundation, focuses on developing rapid diagnostic tests for infectious diseases. The company's core mission is to provide timely and accurate diagnostics to help prevent serious complications from fever-related illnesses. E25Bio's innovative products aim to simplify the identification of infectious diseases, catering primarily to markets that require quick and reliable diagnostic solutions.

Notable affiliations include backing from prestigious investors like the Gates Foundation and NIH, which underscores the credibility and potential impact of E25Bio's technology. Key achievements include the development of rapid diagnostic tests that have the potential to revolutionize disease detection and management. Overall, E25Bio has made significant strides in enhancing public health through its cutting-edge diagnostic tools, aiming to improve healthcare outcomes globally.

E25Bio - Similar Companies

Enable Biosciences logo

Enable Biosciences

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Eclipse Diagnostics logo

Eclipse Diagnostics

Genendeavor logo

Genendeavor

genendeavor.com

ECI Biotech logo

ECI Biotech

ecibiotech.com

Signatur Biosciences logo

Signatur Biosciences

signatur.bio

Accelevir Diagnostics logo

Accelevir Diagnostics

Amplified Sciences logo

Amplified Sciences

Biomirror Diagnostics logo

Biomirror Diagnostics

Burst Diagnostics logo

Burst Diagnostics

burst-dx.com

BioAnalytics logo

BioAnalytics

Aldatu Biosciences logo

Aldatu Biosciences

aldatubio.com

Wpss.Bio logo

Wpss.Bio

wpss.bio

Evanostics logo

Evanostics

Hera Biotech logo

Hera Biotech

herabiotech.com

E25Bio - Quick Facts

Who are E25Bio's competitors?

Companies similar to E25Bio include Enable Biosciences, Prompt Diagnostics, Eclipse Diagnostics and Genendeavor.

When was E25Bio founded?

E25Bio was founded in 2018.

Where is E25Bio's headquarters located?

E25Bio's headquarters is located in Cambridge, MA, US.

When was E25Bio's last funding round?

E25Bio's most recent funding round was for $5.8M (USD) in August 2020.

How much has E25Bio raised to-date?

As of Aug 13, 2020, E25Bio has raised a total of $10.1M (USD).

How many employees does E25Bio have?

E25Bio has 13 employees as of Feb 5, 2024.

E25Bio - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostic Tests
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified